Back to GEN Stock Lookup

Genesis HealthCare (GEN) – Company Press Releases

Nov 22, 2016 04:01 PM Genesis HealthCare Announces Retirement of Mike Reitz Executive Vice President and Chief Operating Officer
Nov 21, 2016 03:46 PM Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) for Relapsed Multiple Myeloma and Updates Financial Guidance
Nov 11, 2016 07:30 AM GeneNews Announces Q3-2016 Financial Results and Provides Corporate Update
Nov 10, 2016 12:15 PM MacKay Shields Expands to West Coast with Opening of Los Angeles Office
Nov 10, 2016 08:27 AM Genmab Announces Phase III Study of Daratumumab in Combination with Carfilzomib in Multiple Myeloma
Nov 7, 2016 03:51 PM Genesis HealthCare to Present at the Stephens Fall Investment Conference on November 8, 2016
Nov 3, 2016 04:01 PM Genesis HealthCare Reports Third Quarter 2016 Results
Nov 2, 2016 12:01 PM Genmab Announces Financial Results for the First Nine Months of 2016 and Improves 2016 Financial Guidance
Nov 2, 2016 09:30 AM Genesis HealthCare Announces New Leases for 92 Facilities Historically Leased From Welltower Inc.
Nov 2, 2016 08:08 AM Cindat and Union Life to Invest in a Welltower U.S. Health Care Real Estate Portfolio
Nov 2, 2016 08:07 AM Welltower Announces Significant Portfolio Repositioning
Oct 31, 2016 03:08 PM Genesis HealthCare to Release Third Quarter 2016 Earnings Results on Thursday, November 3, 2016
Oct 7, 2016 06:07 PM U.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma
Oct 3, 2016 08:00 AM GeneNews Provides Update on GEM and Alumina Financings
Sep 28, 2016 02:46 PM Major Shareholder Announcement
Sep 22, 2016 12:16 PM Major Shareholder Announcement
Sep 19, 2016 07:30 AM GeneNews and NueHealth Announce Partnership in Early Cancer Diagnostics
Sep 12, 2016 10:09 AM Major Shareholder Announcement
Sep 9, 2016 03:16 PM UNM Health System partners with Genesis HealthCare to reduce hospital readmissions
Sep 9, 2016 03:16 PM UNM Health System partners with Genesis HealthCare to reduce hospital readmissions
Sep 7, 2016 09:00 AM Because It Pays to Do the Right Thing, UNITE HERE Launches www.AgainstFraud.org to Help Healthcare Workers Blow the Whistle on Medical Fraud
Aug 31, 2016 11:13 AM Genmab's Total Number of Voting Rights and Total Share Capital
Aug 31, 2016 05:16 AM Genmab Announces U.S. FDA Approval of Arzerra(r) (ofatumumab) in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL
Aug 23, 2016 07:05 AM Genmab Announces European Regulatory Submission for Daratumumab in Relapsed Multiple Myeloma
Aug 17, 2016 03:40 PM Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Relapsed Multiple Myeloma
Aug 11, 2016 07:45 AM GeneNews Announces Q2-2016 Financial Results
Aug 10, 2016 01:07 PM Genmab Enters Commercial License Agreement with Gilead for DuoBody(R) Technology
Aug 9, 2016 11:11 AM Genmab Announces Financial Results for the First Half of 2016 and Improves 2016 Financial Guidance
Aug 4, 2016 04:35 PM Genesis Healthcare Reports Second Quarter 2016 Results
Aug 1, 2016 08:30 AM Genesis HealthCare Makes Significant Headway In Capital Strengthening Initiatives
Jul 26, 2016 04:30 PM GeneNews Provides Financing Update
Jul 25, 2016 08:15 PM Daratumumab Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration in Combination with Standard of Care Regimens for Previously Treated Multiple Myeloma
Jun 30, 2016 06:30 PM GeneNews Announces Election of Directors
Jun 23, 2016 10:33 AM Genmab Provides Update on Marketing Authorization Application for Arzerra(r) (ofatumumab) as Maintenance Therapy for Patients with Relapsed CLL
Jun 16, 2016 10:30 AM GeneNews Meets TSX Continued Listing Requirements
Jun 16, 2016 07:30 AM GeneNews MCTO Lifted
Jun 15, 2016 07:30 AM GeneNews Announces Filing of Q1-2016 Financial Results
Jun 13, 2016 04:18 PM Genesis HealthCare Names Steve Saville President Of CareerStaff Unlimited
Jun 9, 2016 07:30 AM GeneNews Secures CAD $5 Million Capital Commitment From GEM Global Yield Fund
Jun 8, 2016 04:43 PM Twelve Genesis HealthCare Centers Receive Bronze National Quality Award
Jun 2, 2016 01:49 AM Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis
May 30, 2016 10:59 AM Genmab Achieves USD 30 Million Milestone in DARZALEX(r) (daratumumab) Collaboration with Janssen
May 27, 2016 06:00 PM GeneNews Announces Full Year 2015 Financial Results
May 23, 2016 07:15 AM Genmab Announces European Conditional Marketing Authorization for DARZALEX(r) (daratumumab) for Multiple Myeloma
May 20, 2016 08:30 AM GeneNews Issues Trading Status Clarification
May 19, 2016 09:04 AM GeneNews Announces a Further Extension of the TSX’s Remedial Review Process
May 18, 2016 01:28 PM Genmab Announces Positive Topline Result in Phase III POLLUX Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
May 18, 2016 07:00 AM GeneNews Applies For Further Extension of TSX’s Remedial Review Process
May 17, 2016 04:03 PM Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL accepted for priority review by FDA
May 11, 2016 08:00 AM GeneNews Issues MCTO Update

Back to GEN Stock Lookup